These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
807 related items for PubMed ID: 16877298
1. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load. Nose H, Saito M, Usuku K, Sabouri AH, Matsuzaki T, Kubota R, Eiraku N, Furukawa Y, Izumo S, Arimura K, Osame M. J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298 [Abstract] [Full Text] [Related]
2. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE, Bunce M, Eiraku N, Izumo S, Usuku K, Osame M, Bangham CR. J Infect Dis; 2002 Oct 01; 186(7):932-9. PubMed ID: 12232833 [Abstract] [Full Text] [Related]
3. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, Izumo S, Usuku K, Welsh KI, Osame M, Bangham CR. J Immunol; 2000 Dec 15; 165(12):7278-84. PubMed ID: 11120862 [Abstract] [Full Text] [Related]
4. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients. Talledo M, López G, Huyghe JR, Verdonck K, Adaui V, González E, Best I, Clark D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L. J Med Virol; 2010 Mar 15; 82(3):460-6. PubMed ID: 20087941 [Abstract] [Full Text] [Related]
6. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. Sabouri AH, Saito M, Usuku K, Bajestan SN, Mahmoudi M, Forughipour M, Sabouri Z, Abbaspour Z, Goharjoo ME, Khayami E, Hasani A, Izumo S, Arimura K, Farid R, Osame M. J Gen Virol; 2005 Mar 15; 86(Pt 3):773-781. PubMed ID: 15722539 [Abstract] [Full Text] [Related]
9. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals. Saito M, Usuku K, Nobuhara Y, Matsumoto W, Kodama D, Sabouri AH, Izumo S, Arimura K, Osame M. J Neurol Sci; 2004 Apr 15; 219(1-2):157-61. PubMed ID: 15050452 [Abstract] [Full Text] [Related]
10. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers. Furukawa Y, Saito M, Matsumoto W, Usuku K, Tanaka Y, Izumo S, Osame M. J Infect Dis; 2003 Apr 01; 187(7):1116-25. PubMed ID: 12660926 [Abstract] [Full Text] [Related]
12. Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru. Talledo M, López G, Huyghe JR, Verdonck K, González E, Clark D, Senitzer D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L. Hum Immunol; 2010 Aug 01; 71(8):804-8. PubMed ID: 20483367 [Abstract] [Full Text] [Related]
18. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S. AIDS Res Hum Retroviruses; 2000 Nov 01; 16(16):1705-9. PubMed ID: 11080814 [Abstract] [Full Text] [Related]